<SEC-DOCUMENT>0001437749-21-008203.txt : 20210505
<SEC-HEADER>0001437749-21-008203.hdr.sgml : 20210505
<ACCEPTANCE-DATETIME>20210405150036
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001437749-21-008203
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20210405

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NovaBay Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001389545
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				680454536
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		(510) 899-8800

	MAIL ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<html><head><meta charset="utf-8"><meta name="format-detection" content="telephone=no"><!--Created on 4/5/2021 7:20:27 AM --><meta name="generator" content="RDG HTML Converter 3.4.3.0">
	<title>nby20210405_corresp.htm</title>


</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">April 5, 2021</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;margin:0pt;text-indent:36pt;">VIA EDGAR</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Securities and Exchange Commission</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Division of Corporation Finance</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">100 F Street, N.E.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Washington, DC 20549</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Re:</b></p>
			</td>
			<td>
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>NovaBay Pharmaceuticals, Inc. (the </b>&#8220;<b><i>Company</i></b>&#8221;<b>)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Form S-3, File No. 333-254744</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Ladies and Gentlemen:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the Securities and Exchange Commission (the &#8220;<b><i>Commission</i></b>&#8221;) take appropriate action to cause the above-referenced Registration Statement on Form S-3, as amended by Amendment No. 1 to the Form S-3, to become effective as of 5:00 p.m. (Eastern time) on Wednesday, April 7, 2021, or as soon as practicable thereafter.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:2.1%;">&nbsp;</td>
			<td style="vertical-align:middle;width:22.4%;">&nbsp;</td>
			<td colspan="2" style="vertical-align:middle;width:2.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Very truly yours,</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:2.1%;">&nbsp;</td>
			<td style="vertical-align:middle;width:22.4%;">&nbsp;</td>
			<td style="vertical-align:middle;width:2.1%;">&nbsp;</td>
			<td style="vertical-align:middle;width:26.7%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:2.1%;">&nbsp;</td>
			<td style="vertical-align:middle;width:22.4%;">&nbsp;</td>
			<td colspan="2" style="vertical-align:middle;width:2.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>NovaBay Pharmaceuticals, Inc.</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:2.1%;">&nbsp;</td>
			<td style="vertical-align:middle;width:22.4%;">&nbsp;</td>
			<td style="vertical-align:middle;width:2.1%;">&nbsp;</td>
			<td style="vertical-align:middle;width:26.7%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:2.1%;">&nbsp;</td>
			<td style="vertical-align:middle;width:22.4%;">&nbsp;</td>
			<td style="vertical-align:middle;width:2.1%;">&nbsp;</td>
			<td style="vertical-align:middle;width:26.7%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:2.1%;">&nbsp;</td>
			<td style="vertical-align:middle;width:22.4%;">&nbsp;</td>
			<td style="vertical-align:middle;width:2.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:26.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;&nbsp;&nbsp;&nbsp;/s/ Justin Hall</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:2.1%;">&nbsp;</td>
			<td style="vertical-align:middle;width:22.4%;">&nbsp;</td>
			<td style="vertical-align:middle;width:2.1%;">&nbsp;</td>
			<td style="vertical-align:middle;width:26.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Justin Hall</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:2.1%;">&nbsp;</td>
			<td style="vertical-align:middle;width:22.4%;">&nbsp;</td>
			<td style="vertical-align:middle;width:2.1%;">&nbsp;</td>
			<td style="vertical-align:middle;width:26.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Executive Officer and&nbsp;General Counsel</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:2.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">cc:</p>
			</td>
			<td style="vertical-align:middle;width:22.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Abby E. Brown, Squire Patton Boggs (US) LLP</p>
			</td>
			<td style="vertical-align:middle;width:2.1%;">&nbsp;</td>
			<td style="vertical-align:middle;width:26.7%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:2.1%;">&nbsp;</td>
			<td style="vertical-align:middle;width:22.4%;">&nbsp;</td>
			<td style="vertical-align:middle;width:2.1%;">&nbsp;</td>
			<td style="vertical-align:middle;width:26.7%;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
